NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

exwannabe,

For me it's not so much that I think the trial must end but rather that if the pseudos or mesenchymal patients are doing so well that there can be no denial then a resolution with regard to them must be reached and relatively soon ethically speaking. NWBO has learned a great deal about their treatment during the course of this trial and the flexibility built in by trial design is a major reason for this. Linda has said NWBO planned for this trial to go to the very end of schedule and shown she is in no hurry to get there. This has been used against her to great effect but as I see it she does not want to give regulators any reason for concern about this trial other than for positive ethical reasons due to benefit within a subgroup population. The parallel trials seem to make this abundantly clear. Best wishes.